Market Introduction
Drug delivery systems are the technologies primarily used for the controlled or targeted delivery of various therapeutic agents to treat various diseases or improve the health of the patients. Nasal drug delivery is one of the efficient routes of drug administration. It offers needle-free drug delivery, optimal route for brain-targeted therapies, and superior bioavailability. Nasal route of administration is preferred in several disease indications such as Parkinson’s disease, prostate cancer, migraine, and influenza amongst others. Moreover, nasal route is also suitable for the treatment of drug addiction as well as for sedation.
Market Overview and Dynamics
The North America nasal delivery devices market is expected to reach US$ 36,940.74 million in 2027 from US$ 21,932.47 million in 2019. The market is estimated to grow with a CAGR of 6.8% from 2020-2027. The growth of the market is attributed to some key driving factors such as the rising prevalence of respiratory diseases and the superior outcomes of intranasal drug delivery among patients. However, the market growth is likely to be hindered owing to the limitations regarding drug delivery medications.
Key Market Segments
Based on drug type, the nasal delivery devices market is anaesthetics, antibiotics, pain relief drugs, calcium supplements, vasoconstrictors, antihistamines, and others. Based on delivery technologies, the nasal delivery devices market, is segmented into spray, nebulizers, inhalers, and others. Based on end user, the nasal delivery devices market, is segmented into home care settings, hospitals, and clinics.
Major Sources and Companies Listed
Some of the major primary and secondary sources for nasal delivery devices market included in the report are Global Asthma Network, US National Library of Medicine National Institutes of Health, and others.
Reasons to buy the report
NORTH AMERICA NASAL DELIVERY DEVICES MARKET SEGMENTATION
By Country
Company Profiles